78
27
Growth Score 78 in past quarter
-7 pts
Heat Score 27 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
448250
TriMed develops orthopaedic implants to treat complex fractures and musculoskeletal injuries of the upper and lower extremities.
- David Medoff: CEO
- Jeffrey Hendrix: Vice President of Sales Western USPast Role: BioPro, Director of Sales
About the Company
TriMed specializes in the design and development of orthopedic implants designed to treat distal radius fractures through Open Reduction Internal Fixation. The company now offers systems and innovative techniques to treat pathologies of the wrist, ulna, clavicle, elbow, forearm, fifth metatarsal, and ankle.
